UPXI - NASDAQ
Upexi, Inc.
$1.01
-11%Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.
At a Glance
Live SnapshotUpexi, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Upexi, Inc. Income Statement
UPXI • NASDAQ
| Upexi, Inc. Income Statement | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
15.8M | 26M | 36.4M | 23.1M | 24.1M | 7.4M | 2.2M | |
GROSS PROFIT | |||||||
(4.9M) | (13.2M) | (15.4M) | (8.2M) | (12.2M) | (4.8M) | (1.2M) | |
10.9M | 12.8M | 21M | 14.9M | 11.9M | 2.6M | 1M | |
OPERATING INCOME | |||||||
(23.4M) | (35.3M) | (33.3M) | (21.4M) | (10.5M) | (7.4M) | (1.6M) | |
(23M) | (22.5M) | (26.1M) | (19.8M) | (9.4M) | (7.4M) | (1.6M) | |
-12.5M | -22.5M | -12.3M | -6.5M | 1.4M | -4.8M | -589.1K | |
PRE-TAX INCOME | |||||||
(1.2M) | (3.1M) | (4.7M) | (202.1K) | (530.4K) | (138.4K) | (0.0) | |
-1.2M | -3.1M | -4.7M | -202.1K | -530.4K | -138.4K | 3.1K | |
(382.3K) | (12.7M) | (7.2M) | (1.6M) | (1M) | (0.0) | -1.1K | |
-1.2M | -3.1M | -4.7M | 101.1K | 269.4K | -546.5K | 2K | |
-13.7M | -25.6M | -17M | -6.4M | 1.7M | -5.4M | -587K | |
NET INCOME | |||||||
(0.0) | -332.1K | -3M | -518.4K | -1.3M | (545.3K) | -2K | |
-13.7M | -23.7M | -16.9M | -2.1M | 3M | -5.4M | -585K |
SEC Filings
UPXI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 13, 2026 | May 12, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 12, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | May 05, 2026 | June 15, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 31, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 03, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 10, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 09, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 09, 2026 | February 06, 2026 | 2026 |
Related Guides
Continue your UPXI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.